Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000144997 | SCV000051905 | benign | not specified | 2016-05-16 | criteria provided, single submitter | clinical testing | Variant summary: The ABCC8 c.4120-19C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. This variant was found in 604/26462 control chromosomes (11 homozygotes) at a frequency of 0.0228252, which greatly exceeds the estimated maximal expected allele frequency of a pathogenic ABCC8 variant (2.1e-8), suggesting this variant is a benign polymorphism. In addition, one clinical diagnostic laboratory classified this variant as benign. Taken together and based on the prevalence in general population this variant is classified as Benign. |
Prevention |
RCV000144997 | SCV000303809 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001523332 | SCV001733024 | benign | not provided | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533256 | SCV001749067 | benign | Leucine-induced hypoglycemia | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533257 | SCV001749068 | benign | Hyperinsulinemic hypoglycemia, familial, 1 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533258 | SCV001749069 | benign | Diabetes mellitus, transient neonatal, 2 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001533259 | SCV001749070 | benign | Diabetes mellitus, permanent neonatal 3 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001523332 | SCV001856607 | benign | not provided | 2018-10-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16429405, 33410562, 27884173) |
Clinical Genomics, |
RCV002226656 | SCV002505512 | uncertain significance | Hyperinsulinemia | criteria provided, single submitter | research | Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a response to sulfonylureas. Although rs1800853 is prevalent in hyperinsulinemic hypoglycemia in infancy, sufficient evidence is not seen to demonstrate the association of this variant with neonatal diabetes or MODY. | |
Ce |
RCV001523332 | SCV004136027 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | ABCC8: BS1, BS2 |
ARUP Laboratories, |
RCV001523332 | SCV004564120 | benign | not provided | 2023-09-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000144997 | SCV000192033 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001277183 | SCV001464081 | benign | Hereditary hyperinsulinism | 2020-09-16 | no assertion criteria provided | clinical testing |